Tag: FDA

Power loss risks prompt FDA Class 1 recall designation for heart pump accessories

Editor's Note Sudden, unexpected shutdown and restart prompted the US Food and Drug Administration (FDA) to designate a class 1 recall—the most severe category reserved for serious risk of injury or death—for Abbot’s HeartMate Mobile Power Unit, which powers system controllers for the HeartMate 3 Left Ventricular Assist System (LVAS)…

Read More

By: Matt Danford
April 25, 2025
Share

Augmented reality gains FDA nod, 10k-case milestone in orthopedics, strides in outpatient surgery

Editor's Note Augmented reality (AR) guidance keeps surging in perioperative practice: Pixee Medical just secured FDA 510(k) clearance for its Knee+ NexSight system for total knee arthroplasty, while Augmedics’ xvision platform has already guided 10,000 US spine surgical procedures and is rolling out a new CT-Fluoro registration upgrade. According to…

Read More

By: Tarsilla Moura
April 23, 2025
Share

AI monitoring, remote surgery advance

Editor's Note Recent reporting from Fierce Healthcare highlights two notable technology advances that promise to impact surgical patients and caregivers:  an AI-driven blood pressure monitoring system and a remote-controlled endovascular robotics platform. The first development, from BD, is designed to help clinicians anticipate and manage dangerous blood pressure drops during…

Read More

By: Matt Danford
April 23, 2025
Share

FDA issues early alerts for intravascular catheters

Editor's Note The US Food and Drug Administration (FDA) warned of safety risks resulting from manufacturing issues with two varieties of intravascular catheter—Conavi Medical’s Novasight Hybrid line and BD’s PowerPICC intravascular devices—in separate early alerts April 18. In one reported incident, the sheath of a Novasight Hybrid catheter—a device used…

Read More

By: Matt Danford
April 21, 2025
Share

Literature review: Endoscope disinfection failures highlight need for stronger sterilization practices

Editor's Note High-level disinfection (HLD) fails to reliably eliminate harmful microbes from flexible endoscopes in real-world healthcare settings, according to a review of endoscope processing effectiveness published April 8 in the American Journal of Infection Control. The review highlights routine breaches in cleaning protocols and links contaminated endoscopes to numerous…

Read More

By: Matt Danford
April 16, 2025
Share

GAO urges HHS to improve drug shortage response coordination

Editor's Note The Government Accountability Office (GAO) has called on the Department of Health and Human Services (HHS) to implement a formal mechanism for coordinating efforts to address ongoing drug shortages, which continue to jeopardize patient care nationwide. In a report released April 9, 2025, the GAO highlighted the critical…

Read More

By: Matt Danford
April 10, 2025
Share

FDA clears AI platform for real-time surgical measurements

Editor's Note What is reportedly the first technology to allow dynamic, 3D, segmental visualization of anatomy during surgery earned a second 510(k) clearance from the US Food and Drug Administration, according to an April 8 press release from developer Proprio. Designed to let surgeons measure progress during surgery without scrubbing…

Read More

By: Matt Danford
April 9, 2025
Share

Study: MRI contrast agent causes harmful metal buildup in some patients

Editor's Note New research offers a potential explanation for why some patients retain toxic metals long after undergoing an MRI. Published in the journal Magnetic Resonance Imaging, the findings show that gadolinium contrast agents used in MRI scans may react with common dietary compounds to form harmful metal nanoparticles in…

Read More

By: Matt Danford
April 9, 2025
Share

FDA issues Class 1 recall for vascular cannulas

Editor's Note Aortic root cannulas from Medtronic are the subject of the latest US Food and Drug Administration (FDA) class 1 recall, the most serious category reserved for risk of injury or death. Affected products include the DLP Aortic Root Cannula, MiAR Cannula, and DLP Aortic Root Cannula with Vent…

Read More

By: Matt Danford
April 1, 2025
Share

FDA announces Class 1 recall for implantable ports

Editor's Note The US Food and Drug Administration (FDA) has deemed Smiths Medical’s recall of Proport Plastic Implantable Ports a Class 1, the most severe designation indicating serious risk of injury or death. The devices are designed for repeated venous access for injections, infusions, and/or blood samples. According to the…

Read More

By: Matt Danford
March 20, 2025
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat